4//SEC Filing
Aralez Pharmaceuticals Inc. 4
Accession 0001104659-17-018600
CIK 0001660719operating
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:18 PM ET
Size
4.9 KB
Accession
0001104659-17-018600
Insider Transaction Report
Form 4
Charles Scott J
Chief Financial Officer
Transactions
- Sale
Common Shares, without par value
2017-03-20$2.41/sh−5,205$12,544→ 208,163 total
Footnotes (1)
- [F1]This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 15,789 restricted stock units, which were previously granted on March 17, 2016 and which vested on March 17, 2017.
Documents
Issuer
Aralez Pharmaceuticals Inc.
CIK 0001660719
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001660719
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 4:18 PM ET
- Size
- 4.9 KB